Literature DB >> 9989453

Demyelination: the role of reactive oxygen and nitrogen species.

K J Smith1, R Kapoor, P A Felts.   

Abstract

This review summarises the role that reactive oxygen and nitrogen species play in demyelination, such as that occurring in the inflammatory demyelinating disorders multiple sclerosis and Guillain-Barré syndrome. The concentrations of reactive oxygen and nitrogen species (e.g. superoxide, nitric oxide and peroxynitrite) can increase dramatically under conditions such as inflammation, and this can overwhelm the inherent antioxidant defences within lesions. Such oxidative and/or nitrative stress can damage the lipids, proteins and nucleic acids of cells and mitochondria, potentially causing cell death. Oligodendrocytes are more sensitive to oxidative and nitrative stress in vitro than are astrocytes and microglia, seemingly due to a diminished capacity for antioxidant defence, and the presence of raised risk factors, including a high iron content. Oxidative and nitrative stress might therefore result in vivo in selective oligodendrocyte death, and thereby demyelination. The reactive species may also damage the myelin sheath, promoting its attack by macrophages. Damage can occur directly by lipid peroxidation, and indirectly by the activation of proteases and phospholipase A2. Evidence for the existence of oxidative and nitrative stress within inflammatory demyelinating lesions includes the presence of both lipid and protein peroxides, and nitrotyrosine (a marker for peroxynitrite formation). The neurological deficit resulting from experimental autoimmune demyelinating disease has generally been reduced by trial therapies intended to diminish the concentration of reactive oxygen species. However, therapies aimed at diminishing reactive nitrogen species have had a more variable outcome, sometimes exacerbating disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9989453      PMCID: PMC7161906          DOI: 10.1111/j.1750-3639.1999.tb00212.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  254 in total

Review 1.  Biochemistry of peroxisomes.

Authors:  H van den Bosch; R B Schutgens; R J Wanders; J M Tager
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 2.  Induction of superoxide anion and nitric oxide production in cultured microglia.

Authors:  C A Colton; J Snell; O Chernyshev; D L Gilbert
Journal:  Ann N Y Acad Sci       Date:  1994-11-17       Impact factor: 5.691

3.  Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors.

Authors:  S R Ruuls; S Van Der Linden; K Sontrop; I Huitinga; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

4.  Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor.

Authors:  M Yonezawa; S A Back; X Gan; P A Rosenberg; J J Volpe
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

5.  Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes.

Authors:  J E Merrill; S P Murphy; B Mitrovic; A Mackenzie-Graham; J C Dopp; M Ding; J Griscavage; L J Ignarro; C J Lowenstein
Journal:  J Neurosci Res       Date:  1997-05-15       Impact factor: 4.164

6.  Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis.

Authors:  H Langemann; A Kabiersch; J Newcombe
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

7.  Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

Authors:  V Navikas; B He; J Link; M Haglund; M Söderström; S Fredrikson; J Höjeberg; J Qiao; T Olsson; H Link
Journal:  Brain       Date:  1996-02       Impact factor: 13.501

8.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.

Authors:  J S Stamler; D I Simon; J A Osborne; M E Mullins; O Jaraki; T Michel; D J Singel; J Loscalzo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro.

Authors:  R Gold; J Zielasek; R Kiefer; K V Toyka; H P Hartung
Journal:  Cell Immunol       Date:  1996-02-25       Impact factor: 4.868

10.  Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes.

Authors:  J P Bolaños; S Peuchen; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1994-09       Impact factor: 5.372

View more
  145 in total

Review 1.  Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Authors:  Ludwig Kappos; Jens Kuhle; Achim Gass; Lutz Achtnichts; Ernst-Wilhelm Radue
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  Renin-angiotensin system blockers and modulation of radiation-induced brain injury.

Authors:  M E Robbins; W Zhao; M A Garcia-Espinosa; D I Diz
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  Effect of age and calorie restriction on corpus callosal integrity in rhesus macaques: a fiber tractography study.

Authors:  Aadhavi Sridharan; Barbara B Bendlin; Catherine L Gallagher; Jennifer M Oh; Auriel A Willette; Andrew L Alexander; Joseph W Kemnitz; Ricki J Colman; Richard H Weindruch; Sterling C Johnson
Journal:  Neurosci Lett       Date:  2014-03-29       Impact factor: 3.046

Review 4.  Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease.

Authors:  R Shi; J C Page; M Tully
Journal:  Free Radic Res       Date:  2015-04-16

5.  Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage.

Authors:  Jonghyuck Park; Lingxing Zheng; Andrew Marquis; Michael Walls; Brad Duerstock; Amber Pond; Sasha Vega-Alvarez; He Wang; Zheng Ouyang; Riyi Shi
Journal:  J Neurochem       Date:  2013-12-15       Impact factor: 5.372

6.  Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2005-09-15       Impact factor: 7.376

7.  The control of reactive oxygen species production by SHP-1 in oligodendrocytes.

Authors:  Ross C Gruber; Daria LaRocca; Scott B Minchenberg; George P Christophi; Chad A Hudson; Alex K Ray; Bridget Shafit-Zagardo; Paul T Massa
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

8.  JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis.

Authors:  Nana Merabova; Dorota Kaniowska; Rafal Kaminski; Satish L Deshmane; Martyn K White; Shohreh Amini; Armine Darbinyan; Kamel Khalili
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Heather A Bixler; Andrzej Pastuszyn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

10.  The heme precursor delta-aminolevulinate blocks peripheral myelin formation.

Authors:  Natalia Felitsyn; Colin McLeod; Albert L Shroads; Peter W Stacpoole; Lucia Notterpek
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.